- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04412954
Improving Cardiovascular Risk Factors in Black Young Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A total of 256 students, ages 18-25, who meet the inclusion and exclusion criteria will be recruited from Columbus State Community College (CSCC). A sample size of 256 subjects (n=128 per each trial arm) will have sufficient power (>80%) to detect an average between-group difference with a moderate effect size of 0.4. The mixed effect modeling for repeated outcome measures at 6 and 12 months was used for the power calculation using two-sided significance level of 0.05 assuming 1) first-order autoregressive covariance structure, 2) the within-structure correlation of 0.8, and 3) 20% attrition rate at 12-month follow-up. The effect size of 0.4 was reasonably assumed based on data from published trials on weight-loss interventions (an effect size of 0.8 using 8-week social media, 0.3 using 12-week Smartphone intervention, and 0.6 using 4-month text messaging). Investigators will conduct stratified recruitment by gender (female vs. male) and ethnicity (Non-Hispanic Black vs. Hispanic Black) to achieve a study sample with 80% Non-Hispanic Black and 20% Hispanic and 50% male in each ethnic group. The recruitment and randomization will be equally distributed with approximately 10 subjects per month, which is a feasible enrollment target considering the pool of eligible participants and our previous recruitment success.
Prospective participants who contact through telephone or email will undergo a preliminary screening via telephone and receive an explanation of the study. Included in this screening are four questions from the Eating Attitude Test-26 (EAT-26), which will be asked to determine symptoms of disordered eating in the past 6 months. Those who seem to meet eligibility criteria and are interested in participating will be scheduled for an in person visit for the informed consent and screening process.
Following the informed consent process and baseline visit questionnaires, participants will be randomly assigned to intervention or the attention-control group. Investigators will use stratified randomization by sex (female vs. male) and ethnicity (Non-Hispanic Black vs. Hispanic Black). For each gender strata, randomization will occur in permuted blocks of varying block sizes. Subjects in each block will be randomly assigned to intervention arm or attention-control arm with an allocation ratio of 1:1. The advantage of permuted block randomization is that it will ensure balance in the number of subjects in the two trial arms during the entire study period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion
- age 17-25 years
- Current CSCC student
- Identify as Black
- BMI ≥ 25
- Speaks and reads English
- Interested in losing weight through diet and physical activity changes
- Owns a smartphone or iPhone Operating System (iOS) or Android compatible device
- Ability to return for 12-month visit
Exclusion
- currently pregnant or planning to become pregnant in next 12 months
- Currently participating in another structured weight loss program or taking weight loss medications or medication known to increase weight
- Lost 10% or more of body weight in past 6 months
- Screens positive for disordered eating symptoms
- diagnosed with type I diabetes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Health coach with Smartphone application for diet and physical activity
|
The program includes (1) use of a free commercially available smartphone application program for 12 months, (2) a wearable Fitbit Charge device that will be provided by the study to monitor active minutes, and (3) one 45-minute behavioral counseling session focused on healthy eating and exercise and (4) personalized text messaging for 6 months by a health coach.
The health coach will not send feedback during months 6-12.
The intervention will be fully self-directed in these months, as there will be no contact between the 6 months visit and 12-month visit.
|
|
No Intervention: Control
No intervention, using a Smartphone application for sleep monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Weight
Time Frame: Baseline to 12 months
|
Body weight will be measured in light clothing without shoes using the Tanita Body Scale (BS)
|
Baseline to 12 months
|
|
Physical Activity-Active Minutes/Day
Time Frame: 12 months
|
Will be measured objectively using the FitBit Charge for 7 days at each time period of data collection.
Average active minutes per day will be used as measurement.
This data represents active minutes per day at 12 months
|
12 months
|
|
Physical Activity-Steps/Day
Time Frame: 12 months
|
Will be measured objectively using the FitBit Charge for 7 days at each time period of data collection.
Average steps taken per day will be used as measurement.
|
12 months
|
|
Food Frequency Questionnaire (FFQ)
Time Frame: 12 months
|
The full-length block FFQ will be used to assess diet for 7 days at each period of data collection.
This is not a scale, this is a measure of foods consumed over a period of 7 days.
We measured and target sodium as the nutrient of choice to analyze
|
12 months
|
|
Healthy Eating Index (HEI)
Time Frame: 12 months
|
A healthy eating index score will be calculated at each time period from the FFQ.
The scale ranges from 0-100 with 100 being the best possible score indicating healthy diet aligning with key dietary recommendations.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Participants Who Are Adherent to Self-Monitoring
Time Frame: Baseline to 12 months
|
Intervention condition only.
Adherence will be defined as those participants who enter at least 50% of their caloric goal on at least 80% of days (or 24 days per months).
|
Baseline to 12 months
|
|
Dietary Self-Efficacy Scale (Diet-SE)
Time Frame: 12 months
|
14 questions that examine the participant's belief in their ability to cut down on high caloric foods.
Scale ranges from 0-4 with 0 being "not at all confident" and 4 being "very confident" Higher overall score indicates higher levels of self confidence.
Total score ranges from 0-56.
Total score is reported.
|
12 months
|
|
Self-Efficacy for Exercise Scale
Time Frame: 12 months
|
9 questions that examine the participant's belief in their ability to complete physical activity in given circumstances.
Scale ranges from 0-10 with 0 being not at all confident and 10 being the most confident.
Overall scores range from 0-90 with 90 indicating high confidence levels for exercise.
|
12 months
|
|
Experiences of Discrimination Scale (EoD)
Time Frame: 12 months
|
Examines perceived experiences of discrimination in given circumstances, such as work, public settings, banks, schools, medical care.
17 questions total.
Scale ranges from never to four or more times.
Four or more times being selected indicates higher levels of discrimination experiences.
Total score reported.
Higher score means higher levels of discrimination.
Total score can range from 0 - 68
|
12 months
|
|
Patient Health Questionnaire (PHQ) for Adults, PHQ-9
Time Frame: 12 months
|
Measures depressive symptoms using the patient health questionnaire for adults.
Questions are scored from 0-3, with lower scores indicating no/lower depressive symptoms.
Total score can range from 0-27
|
12 months
|
|
Ideal Body Image
Time Frame: 12 months
|
Measures patient perception of their current body image and their ideal body.
image using a graphic scale ranging from 0-9, with 9 indicating higher levels of overweight/obesity.
|
12 months
|
|
Treatment Self-Regulation Questionnaire (TSRQ) for Diet and Exercise
Time Frame: 12 months
|
30 questions to measure motivation to lose weight by examining three types of motivation.
Scale ranges from 0-7 with 0 being "not at all" and 7 being "very true".
A higher score indicates higher levels of motivation for diet and exercise habits.
Total score can range from 0 - 210
|
12 months
|
|
NIH Patient Reported Outcome Measurement Information System (PROMIS) Measure for Emotional Support
Time Frame: 12 months
|
16 questions to measure perceived levels of emotional support.
Scale ranges from 1-5 with 1 being "never" and 5 being "always.
A higher level score indicates higher level of emotional support.
Total scores can range from 16-80
|
12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Stephens J, Randolph J, Burke L, Miller C, Tan A, Buffington B, Melnyk B, Perkins A. A randomized controlled trial for reduction of risk factors for cardiovascular disease in young adults: Methods of the Aspire study. Contemp Clin Trials. 2022 Oct;121:106873. doi: 10.1016/j.cct.2022.106873. Epub 2022 Sep 5.
- Leissa SM, Randolph JC, Stephens JD. Recruitment of Black Identifying Young Adults into Clinical Trials: a Report from the Field. J Urban Health. 2021 Oct;98(Suppl 2):155-159. doi: 10.1007/s11524-021-00569-4. Epub 2021 Aug 13. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2019B0560
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Smartphone + Text Messaging with Health Coach
-
Center for Innovative Public Health ResearchUniversity of Miami; Ann and Robert H Lurie Childrens Hospital of ChicagoRecruiting
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedCOVID-19United States
-
Washington University School of MedicineCompletedObesity | Overweight | Severe Mental DisorderUnited States
-
VA Office of Research and DevelopmentVA Office of Connected CareCompleted
-
Taipei Medical UniversityCompleted
-
University Hospital, BrestUnknownPhysical Activity | Pregnant | Mobile Health AppsFrance
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
University of Texas Southwestern Medical CenterThe Texas Child Mental Health Care Consortium (TCMHCC)Not yet recruitingSuicide | Suicide Attempt
-
University GhentFund for Scientific Research, Flanders, BelgiumCompletedPhysical ActivityBelgium
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); University of MichiganRecruiting